The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Angiogenesis after acute myocardial infarction
Abstract
Acute myocardial infarction (MI) inflicts massive injury to the coronary microcirculation leading to vascular disintegration and capillary rarefication in the infarct region. Tissue repair after MI involves a robust angiogenic response that commences in the infarct border zone and extends into the necrotic infarct core. Technological advances in several areas have provided novel mechanistic understanding of postinfarction angiogenesis and how it may be targeted to improve heart function after MI. Cell lineage tracing studies indicate that new capillary structures arise by sprouting angiogenesis from pre-existing endothelial cells (ECs) in the infarct border zone with no meaningful contribution from non-EC sources. Single-cell RNA sequencing shows that ECs in infarcted hearts may be grouped into clusters with distinct gene expression signatures, likely reflecting functionally distinct cell populations. EC-specific multicolour lineage tracing reveals that EC subsets clonally expand after MI. Expanding EC clones may arise from tissue-resident ECs with stem cell characteristics that have been identified in multiple organs including the heart. Tissue repair after MI involves interactions among multiple cell types which occur, to a large extent, through secreted proteins and their cognate receptors. While we are only beginning to understand the full complexity of this intercellular communication, macrophage and fibroblast populations have emerged as major drivers of the angiogenic response after MI. Animal data support the view that the endogenous angiogenic response after MI can be boosted to reduce scarring and adverse left ventricular remodelling. The improved mechanistic understanding of infarct angiogenesis therefore creates multiple therapeutic opportunities. During preclinical development, all proangiogenic strategies should be tested in animal models that replicate both cardiovascular risk factor(s) and the pharmacotherapy typically prescribed to patients with acute MI. Considering that the majority of patients nowadays do well after MI, clinical translation will require careful selection of patients in need of proangiogenic therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–212 of 212
Extracellular proteomes of M‐CSF (CSF‐1) and GM‐CSF‐dependent macrophages
Bailey, M. J., Lacey, D. C., de Kok, B., Veith, P. D., Reynolds, E. C., & Hamilton, J. A. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.92 · Cited by 24
Matteucci, M., Casieri, V., Gabisonia, K., Aquaro, G. D., Agostini, S., Pollio, G., Diamanti, D., Rossi, M., Travagli, M., Porcari, V., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw214 · Cited by 24
Li, Y., Yao, Y., Li, J., Chen, Q., Zhang, L., & Wang, Q. K. (2019) · The FASEB Journal · doi:10.1096/fj.201900060r · Cited by 23
Ghadge, S. K., Messner, M., Pham, T. V. H., Doppelhammer, M., Petry, A., Görlach, A., Husse, B., Franz, W., & Zaruba, M. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1543-3 · Cited by 22
Local pharmacological induction of angiogenesis: Drugs for cells and cells as drugs
Gaspar, D., Peixoto, R., Pieri, A. D., Striegl, B., Zeugolis, D. I., & Raghunath, M. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.06.002 · Cited by 22
Järvinen, T. A. H., & Pemmari, T. (2020) · Nanomaterials · doi:10.3390/nano10020226 · Cited by 21
Fraccarollo, D., Galuppo, P., Sieweke, J., Napp, L. C., Grobbecker, P., & Bauersachs, J. K. (2015) · ESC Heart Failure · doi:10.1002/ehf2.12053 · Cited by 18
Theurl, M., Schgoer, W., Albrecht-Schgoer, K., Lener, D., Wolf, D., Wolf, M., Demetz, E., Tymoszuk, P., Tancevski, I., Fischer‐Colbrie, R., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu237 · Cited by 18
Bmi1-Progenitor Cell Ablation Impairs the Angiogenic Response to Myocardial Infarction
Herrero, D., Cañón, S., Pelacho, B., Salvador‐Bernáldez, M., Aguilar, S., Pogontke, C., Carmona, R. M., Salvador, J. M., Pérez-Pomares, J. M., Klein, O. D., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310778 · Cited by 18
Kurotsu, S., Osakabe, R., Isomi, M., Tamura, F., Sadahiro, T., Muraoka, N., Kojima, H., Haginiwa, S., Tani, H., Nara, K., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.094 · Cited by 17
Polten, F., Reboll, M. R., Widera, C., Kempf, T., Bethmann, K., Gupta, P., Miglietta, J. J., Pekcec, A., Tillmanns, J., Bauersachs, J. K., et al. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03041 · Cited by 15
Self-citationSupplemental Oxygen Protects Heart Against Acute Myocardial Infarction
Prabhat, A. M., Kuppusamy, M. L., Naidu, S. K., Meduru, S., Reddy, P. T., Dominic, A., Khan, M., Rivera, B. K., & Kuppusamy, P. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00114 · Cited by 11
Cited by
Signaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 831
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Zhang, M., Liu, Q., Meng, H., Duan, H., Liu, X., Wu, J., Gao, F., Wang, S., Tan, R., & Yuan, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01688-x · Cited by 712
Frantz, S., Hundertmark, M. J., Schulz-Menger, J., Bengel, F. M., & Bauersachs, J. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac223 · Cited by 606
Transforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 344
Cell-cell interactions in the heart: advanced cardiac models and omics technologies
Tan, S., Yang, J., Hu, S., & Lei, W. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03982-z · Cited by 30
Metadata
- Authors
- Wu, X., Reboll, M. R., Korf-Klingebiel, M., & Wollert, K. C.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-16
- Volume
- 117
- Issue
- 5
- Pages
- 1257-1273
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W3092726210
- Cited by
- 379
- References
- 212
- FWCI
- 18.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.